Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

305
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
305
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

152
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
152
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

97
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
97

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regenerative Peripheral Nerve Interface (RPNI) and vascularized Denervated Muscle Targets (VDMT): a preclinical rabbit model as a translational feasibility and methodological platform.

Journal of translational medicine·2026
Same author

Concentric Versus Delta Bipolar Probes for Intraneural Fascicle Selection: A Rabbit Model Study.

Plastic and reconstructive surgery. Global open·2026
Same author

Pharmacovigilance Assistant: An Agentic Workflow for Reproducible Drug Safety Summaries.

Studies in health technology and informatics·2026
Same author

Non-Invasive Prediction of Embryo Ploidy from Time-Lapse Videos Using Video Vision Transformers (ViViT).

Studies in health technology and informatics·2026
Same author

Transformer-Based Architecture for Predicting Surgical Complications from EHR Data.

Studies in health technology and informatics·2026
Same author

A representational framework for learning and encoding structurally enriched trajectories in complex agent environments.

Neural networks : the official journal of the International Neural Network Society·2026

Related Experiment Video

Updated: Jun 6, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Survival Stacking Ensemble Model for Lung Cancer Risk Prediction.

Eduardo Alonso1,2, Xabier Calle1, Ibai Gurrutxaga2

  • 1Vicomtech Foundation, Basque Research and Technology Alliance (BRTA), Donostia - San Sebastián, Spain.

Studies in Health Technology and Informatics
|November 22, 2024
PubMed
Summary
This summary is machine-generated.

A new lung cancer risk model uses fewer features for improved accessibility and performance. This simplified approach enhances early detection and clinical implementation for lung cancer risk assessment.

Keywords:
Cancerensemble modelsmachine learningrisk factors

More Related Videos

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Related Experiment Videos

Last Updated: Jun 6, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Area of Science:

  • Oncology
  • Biostatistics
  • Machine Learning in Healthcare

Background:

  • Smoking is the primary risk factor for lung cancer (LC), causing approximately 85% of cases.
  • Existing tools like the Lung Cancer Risk Assessment Tool (LCRAT) predict LC risk using multiple factors.
  • There is a need for more accessible and easily implementable risk assessment models in clinical practice.

Purpose of the Study:

  • To develop and validate a simplified, feature-reduced model for lung cancer risk prediction.
  • To improve upon the performance and accessibility of current lung cancer risk assessment tools.
  • To enhance the robustness and generalizability of lung cancer risk prediction models through ensemble methods.

Main Methods:

  • A simplified stacking ensemble model was developed using a reduced feature set.
  • The model was trained and tested on data from two large US cohorts: the National Lung Screening Trial (NLST) and the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
  • Model performance was evaluated using Area Under the Curve (AUC) and percentage of positives detected.

Main Results:

  • The proposed simplified model achieved an AUC of 0.799, comparable to the established LCRAT (AUC 0.782).
  • In the top 50% of the population, both models detected a similar proportion of cases (0.766 for the new model vs. 0.754 for LCRAT).
  • The ensemble approach enhanced model robustness and efficiency.

Conclusions:

  • A simplified, feature-reduced lung cancer risk model demonstrates competitive performance and improved accessibility.
  • The ensemble method enhances the reliability and generalizability of lung cancer risk prediction.
  • This model offers a promising, more implementable alternative for routine healthcare settings.